fig6

Reversal of doxorubicin resistance in lung cancer cells by neferine is explained by nuclear factor erythroid-derived 2-like 2 mediated lung resistance protein down regulation

Figure 6. NRF2 regulates LRP expression in lung cancer cells treated with Nef and Dox. A-D: representative western blot analysis of A549 and A549/Dox cells treated with Dox alone, Nef alone and Nef and Dox combination and densitometric analysis are shown for the proteins p-NRF2 and HO-1; E, F: A549 or A549/Dox cells were knocked out for NRF2 using siNRf2 and treated with Dox in combination with Nef. Cell lysates were analyzed for LRP expression and a representative image and densitometric analysis were shown. GAPDH served as internal control for western blots. The results in the graph shown are mean ± SEM and *** represents P < 0.01 which are 3 separate experiments performed in triplicate. Nef: Neferine; Dox: Doxorubicin; NRF2: nuclear factor erythroid-derived 2-like 2; LRP: lung resistance protein; GAPDH: Glyceraldehyde 3-phosphate dehydrogenase

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/